Alaunos Therapeutics, Inc. (TCRT)

Home
TCRT
Financials

2.02 (USD) • At close November 7, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue Numbers are in millions	0.005	2.922	0.398	0	0	0.146	6.389	6.861	4.332	1.373	0.8	0.8	0.667	0	0	0	0	0	0	0	0	0.003	0.002
Cost of Revenue Numbers are in millions	2.315	2.759	0.74	1.128	0.629	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	-2.31	0.163	-0.342	-1.128	-0.629	0.146	6.389	6.861	4.332	1.373	0.8	0.8	0.667	0	0	0	0	0	0	0	0	0.003	0.002
Gross Profit Ratio Numbers are in millions	-462	0.056	-0.859	0	0	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	1	1
Reseach & Development Expenses Numbers are in millions	16.279	25.018	49.643	52.696	38.331	34.134	45.084	157.791	106.785	32.706	42.852	83.446	57.083	12.91	4.556	17.245	18.993	10.391	5.594	0	0	0	0
General & Administrative Expenses Numbers are in millions	12.219	13.142	27.564	27.665	19.527	19.918	14.798	14.377	17.647	12.166	15.661	19.523	14.984	11.636	7.567	8.374	0.773	8.72	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	-2.315	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.805	0	0	0	0	0	0
SG&A Numbers are in millions	9.904	13.142	27.564	27.665	19.527	19.918	14.798	14.377	17.647	12.166	15.661	19.523	14.984	11.636	7.567	8.374	9.578	8.72	4.194	0.039	0.035	0	0
Other Expenses Numbers are in millions	1.048	0.529	-1.202	0.385	0.813	0.631	0.465	0.134	0.012	-0.005	-0.579	-0.013	0	0	0	0	0	10.391	0	0	0	0.043	0.074
Operating Expenses Numbers are in millions	26.183	38.16	77.207	80.361	57.858	54.052	59.882	172.168	124.432	44.872	58.513	102.969	72.067	24.546	12.123	25.619	28.57	19.112	9.787	0.039	0.036	0.043	0.074
Operating Income Numbers are in millions	-28.493	-35.105	-77.549	-80.361	2.264	-53.906	-53.493	-165.307	-120.1	-43.499	-57.713	-102.169	-71.4	-24.546	-12.123	-25.619	-28.57	-19.112	-9.787	-0.039	-0.036	-0.04	-0.073
Operating Income Ratio Numbers are in millions	-5,698.6	-12.014	-194.847	0	0	-369.219	-8.373	-24.094	-27.724	-31.682	-72.141	-127.711	-107.046	0	0	0	0	0	0	0	0	-15.541	-42.025
Total Other Income Expenses Net Numbers are in millions	-6.647	-2.625	-1.202	0.385	-120.06	0.789	-0.83	0.01	0.012	11.718	0.606	6.037	7.622	-8.124	4.474	0.388	0	1.255	0	0	0	0	0
Income Before Tax Numbers are in millions	-35.14	-37.73	-78.751	-79.976	-117.796	-53.117	-54.323	-165.297	-120.088	-31.781	-57.107	-96.132	-63.778	-32.67	-7.649	-25.231	0	-17.857	0	-0.039	-0.036	-0.04	-0.073
Income Before Tax Ratio Numbers are in millions	-7,028	-12.912	-197.867	0	0	-363.815	-8.503	-24.092	-27.721	-23.147	-71.384	-120.165	-95.619	0	0	0	0	0	0	0	0	-15.541	-42.025
Income Tax Expense Numbers are in millions	2.147	-0.133	-1.857	-1.128	60.122	-0.947	2.125	0.114	-0.012	-23.441	-1.791	-12.087	-15.244	16.248	-8.948	-0.388	-1.962	-1.255	-0.27	0	0	0	0
Net Income Numbers are in millions	-35.14	-37.597	-76.894	-78.848	-177.918	-53.117	-54.323	-165.297	-120.088	-31.781	-57.107	-96.132	-63.778	-32.67	-7.649	-25.231	-26.608	-17.857	-9.517	-0.039	-0.036	-0.04	-0.073
Net Income Ratio Numbers are in millions	-7,028	-12.867	-193.201	0	0	-363.815	-8.503	-24.092	-27.721	-23.147	-71.384	-120.165	-95.619	0	0	0	0	0	0	0	0	-15.541	-42.025
EPS Numbers are in millions	-2.2	-2.6	-5.38	-5.64	-15.89	-0.37	-0.4	-1.27	-0.96	-0.31	-0.66	-1.22	-0.97	-0.71	-0.33	-1.19	-1.41	-1.42	-2.32	-0.65	-18.31	-0.36	-0.8
EPS Diluted Numbers are in millions	-2.2	-2.6	-5.38	-5.64	-15.89	-0.37	-0.4	-1.27	-0.96	-0.31	-0.66	-1.22	-0.97	-0.71	-0.33	-1.19	-1.41	-1.42	-2.32	-0.65	-18.31	-0.36	-0.8
EBITDA Numbers are in millions	-26.178	-34.709	-76.069	-80.361	2.893	-54.064	-52.198	-165.183	-120.1	-55.222	-58.16	-107.561	-78.754	-16.234	-16.597	-25.231	-28.137	-18.938	-9.686	-0.039	-0.035	-0.039	-0.072
EBITDA Ratio Numbers are in millions	-5,235.6	-11.879	-191.128	0	0	-370.301	-8.17	-24.076	-27.724	-40.22	-72.7	-134.451	-118.072	0	0	0	0	0	0	0	0	-15.23	-41.59

Alaunos Therapeutics, Inc.

NASDAQ:TCRT Add to watchlist

NASDAQ:TCRT